Search results for "Alzheimer's"

showing 10 items of 308 documents

2015

AbstractLow-frequency magnetic fields (LF-MF) generated by power lines represent a potential environmental health risk and are classified as possibly carcinogenic by the World Health Organization. Epidemiological studies indicate that LF-MF might propagate neurodegenerative diseases like Alzheimer's disease (AD) or amyotrophic lateral sclerosis (ALS). We conducted a comprehensive analysis to determine whether long-term exposure to LF-MF (50 Hz, 1 mT) interferes with disease development in established mouse models for AD and ALS, namely APP23 mice and mice expressing mutant Cu/Zn-superoxide dismutase (SOD1), respectively. Exposure for 16 months did not aggravate learning deficit of APP23 mic…

MultidisciplinaryGlial fibrillary acidic proteinbiologyMicrogliaSOD1Diseasemedicine.diseasemedicine.disease_causePathogenesismedicine.anatomical_structureImmunologybiology.proteinmedicineAlzheimer's diseaseAmyotrophic lateral sclerosisOxidative stressScientific Reports
researchProduct

2015

We present a method to discover discriminative brain metabolism patterns in [18F] fluorodeoxyglucose positron emission tomography (PET) scans, facilitating the clinical diagnosis of Alzheimer's disease. In the work, the term "pattern" stands for a certain brain region that characterizes a target group of patients and can be used for a classification as well as interpretation purposes. Thus, it can be understood as a so-called "region of interest (ROI)". In the literature, an ROI is often found by a given brain atlas that defines a number of brain regions, which corresponds to an anatomical approach. The present work introduces a semi-data-driven approach that is based on learning the charac…

Multidisciplinarymedicine.diagnostic_testbusiness.industryComputer scienceModel selectionBrain atlasMagnetic resonance imagingPattern recognitionMixture modelmedicine.diseasecomputer.software_genreBrain regionNeuroimagingDiscriminative modelPositron emission tomographyVoxelRegion of interestmedicineArtificial intelligenceAlzheimer's diseaseNuclear medicinebusinesscomputerAlzheimer's Disease Neuroimaging InitiativePLOS ONE
researchProduct

Insulin Nanogel as New Strategy for the Treatment of Alzheimer’s Disease

2015

A growing body of evidence shows that Insulin, Insulin Receptor (IR) and IR signaling are involved in brain cognitive functions and their dysfunction is implicated in neuronal degeneration associated with Alzheimer's disease (AD). Thus, the administration of insulin to the brain could be a strategy for the prevention and treatment of AD disease. With this aim, we have designed, synthesized and characterized a nanogel system (NG) that can be used as substrate for the conjugation of insulin and/or fluorescent molecules relevant for their characterization. In particular, a carboxyl-functionalized poly(N-vinyl pyrrolidone) nanogel system, has been produced by ionizing radiation starting from th…

Nanogels Insulin Alzheimer's DiseaseSettore CHIM/07 - Fondamenti Chimici Delle TecnologieSettore BIO/09 - FisiologiaSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)
researchProduct

Modifications de l’olfaction au cours du vieillissement et de certaines pathologies neurodégénératives : mise au point

2015

Olfaction is a complex sensory system, and increasing interest is being shown in the link between olfaction and cognition, notably in the elderly. In this literature review, we revisit the specific neurophysiological features of the olfactory system and odorants that lead to a durable olfactory memory and an emotional memory, for which the implicit component produces subconscious olfactory conditioning. Olfaction is known to affect cognitive abilities and mood. We also consider the impairment of olfactory function due to ageing and to neurodegenerative diseases, in particular Alzheimer's disease and Parkinson's disease, through anatomopathological changes in the peripheral and central olfac…

Olfactory systemSensory stimulation therapybusiness.industryGastroenterologyCognitionSensory systemOlfactionmedicine.disease3. Good health03 medical and health sciences0302 clinical medicineInternal MedicinemedicineDementia030212 general & internal medicineOlfactory memoryAlzheimer's diseasebusinessNeuroscience030217 neurology & neurosurgeryLa Revue de Médecine Interne
researchProduct

proNGF Measurement in Cerebrospinal Fluid Samples of a Large Cohort of Living Patients With Alzheimer's Disease by a New Automated Immunoassay

2021

The discovery of new biomarkers for Alzheimer's disease (AD) is essential for an accurate diagnosis, to conceive new strategies of treatments, and for monitoring the efficacy of potential disease-modifying therapies in clinical trials. proNGF levels in the cerebrospinal fluid (CSF) represent a promising diagnostic biomarker for AD, but its validation was hampered by the absence of a reliable immunoassay. In the literature, proNGF is currently measured in postmortem brain tissue by semiquantitative immunoblot. Here we describe the development and validation of a new method to measure proNGF in the CSF of living patients. This method, based on molecular size separation by capillary electropho…

OncologyAgingmedicine.medical_specialtydiagnosisCognitive NeuroscienceNeurosciences. Biological psychiatry. NeuropsychiatryDiseaseSettore BIO/09 - FisiologiaCerebrospinal fluidneurodegenerative diseaseInternal medicinemedicineDiagnostic biomarkerneurodegenerative diseasesproNGFimmunoassayOriginal Researchmedicine.diagnostic_testbusiness.industrySignificant differenceAlzheimer's diseaseLarge cohortdiagnosiImmunoassayBiomarker (medicine)biomarkerAutomated immunoassaybusinessRC321-571Neuroscience
researchProduct

Association between the interleukin-1beta polymorphisms and Alzheimer's disease: a systematic review and meta-analysis.

2008

Abstract The pro-inflammatory cytokine interleukin(IL)-1β is a main component in inflammatory pathways and is overexpressed in the brain of Alzheimer's disease (AD) patients. Several studies report associations between IL-1β polymorphisms and AD, but findings from different studies are controversial. Our aim was to verify the correlation between the single nucleotide polymorphisms (SNPs) of the IL-1β, at sites − 511 and + 3953, and AD by meta-analysis. Computerized bibliographic searches of PUBMED and AlzGene database ( http://www.alzgene.org ) were supplemented with manual searches of reference lists. There is evidence for association between IL-1β + 3953 SNP and AD, with an OR = 1.60 (95%…

OncologyDatabases Factual statistics /&/ numerical datamedicine.medical_specialtyDatabases FactualAlzheimer's disease IL-1β −511 IL-1β +3953 Polymorphism Meta-analysisPopulationInterleukin-1betaSingle-nucleotide polymorphismSubgroup analysisAlzheimer Disease geneticsMeta-Analysis as TopicPolymorphism (computer science)Alzheimer DiseaseInternal medicineGenotypemedicineSNPHumanseducationSettore MED/04 - Patologia Generaleeducation.field_of_studyPolymorphism Geneticbusiness.industryGeneral NeuroscienceComputational Biologymedicine.diseaseMeta-analysisImmunologyNeurology (clinical)Alzheimer's diseasebusinessInterleukin-1beta genetics
researchProduct

P53 Aggregates and Interacts with Tau in Alzheimer's Disease

2020

P53Alzheimer's diseaseTauprotein aggregation
researchProduct

Implications of alpha- and beta-secretase expression and function in Alzheimer's disease

2020

Abstract There has been intense debate in the field about the extent to which processing of the amyloid precursor protein contributes to pathogenesis of Alzheimer's disease. Early publications succeeding in the identification of the main component of senile plaques—the amyloid-beta (A-beta) peptide—strictly argued for a constitutive contribution of A-beta to disease initiation and progression. This led to development of the amyloid hypothesis, which in recent years was attacked for the lack of success of clinical studies based on the respective assumption. There is evidence that the hypothesis must be revisited, but accumulation of A-beta along with aging might still be the best explanation…

PathogenesisbiologyADAM10biology.proteinAmyloid precursor proteinAlpha (ethology)DiseaseAmyloid precursor protein secretaseNeuroscienceFunction (biology)Biochemistry of Alzheimer's disease
researchProduct

Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative da…

2001

In the aging dog brain lesions develop spontaneously. They share some morphological characteristics with those of Alzheimer 's disease in man. Diffuse and primitive plaques are well known, whereas neuritic plaques rarely develop. Neurofibrillary tangles have not been seen in the canine. The aim of the present investigation was to study major age-related changes of the dog's brain using paraffin sections with respect to cross-immunoreactivity of tau, A beta protein and other immunoreactive components including hydroxynonenal protein, which is a marker for oxidative damage. The occurrence of neurofibrillary tangles and of the protein tau therein was studied in serial brain sections of two dog…

Pathologymedicine.medical_specialtyAgingAmyloidmedicine.drug_classTau proteinModels NeurologicalNerve Tissue ProteinsPlaque AmyloidMonoclonal antibodymedicine.disease_causeDogsAlzheimer DiseaseInternal MedicinemedicineAnimalsHumansSenile plaquesDog DiseasesAldehydesbiologyChemistryBrainNeurofibrillary Tanglesmedicine.diseaseImmunohistochemistryOxidative StressPolyclonal antibodiesbiology.proteinImmunohistochemistryAlzheimer's diseaseOxidative stressAmyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
researchProduct

Molecular mechanisms linking amyloid β toxicity and Tau hyperphosphorylation in Alzheimer׳s disease

2015

Neurofibrillary tangles (aggregates of cytoskeletal Tau protein) and senile plaques (aggregates mainly formed by amyloid β peptide) are two landmark lesions in Alzheimer׳s disease. Some researchers have proposed tangles, whereas others have proposed plaques, as primary lesions. For a long time, these were thought of as independent mechanisms. However, experimental evidence suggests that both lesions are intimately related. We review here some molecular pathways linking amyloid β and Tau toxicities involving, among others, glycogen synthase kinase 3β, p38, Pin1, cyclin-dependent kinase 5, and regulator of calcineurin 1. Understanding amyloid β and Tau toxicities as part of a common pathophys…

Pathologymedicine.medical_specialtyAmyloid beta-PeptidesbiologyChemistryKinaseNeurodegenerationTau proteinBACE1-AStau Proteinsmedicine.diseaseProtein Aggregation PathologicalBiochemistryBiochemistry of Alzheimer's diseaseAlzheimer DiseaseGSK-3Physiology (medical)mental disordersmedicinebiology.proteinCancer researchPIN1HumansSenile plaquesPhosphorylationFree Radical Biology and Medicine
researchProduct